These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Paclitaxel (175 mg/m2) plus carboplatin versus paclitaxel (225 mg/m2) plus carboplatin in non-small cell lung cancer: a randomized study. Kosmidis P, Mylonakis N, Fountzilas G, Samantas E, Athanassiadis A, Pavlidis N, Skarlos D. Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-30-S12-33. PubMed ID: 9331117 [Abstract] [Full Text] [Related]
28. Treatment of metastatic breast cancer with paclitaxel and doxorubicin. Dombernowsky P, Gehl J, Boesgaard M, Jensen TP, Jensen BW, Ejlertsen B. Semin Oncol; 1995 Dec; 22(6 Suppl 15):13-7. PubMed ID: 8643964 [Abstract] [Full Text] [Related]
29. Combination regimens of paclitaxel and the platinum drugs as first-line regimens for ovarian cancer. Ozols RF. Semin Oncol; 1995 Dec; 22(6 Suppl 15):1-6. PubMed ID: 8643963 [Abstract] [Full Text] [Related]
30. Paclitaxel and carboplatin in inoperable non-small cell lung cancer. Kosmidis P, Mylonakis N, Fountzilas G, Samantas E, Athanasiadis A, Skarlos D. Semin Oncol; 1996 Dec; 23(6 Suppl 16):68-70. PubMed ID: 9007126 [Abstract] [Full Text] [Related]